TN2013000186A1 - Anti-il-23 antibodies - Google Patents
Anti-il-23 antibodiesInfo
- Publication number
- TN2013000186A1 TN2013000186A1 TNP2013000186A TN2013000186A TN2013000186A1 TN 2013000186 A1 TN2013000186 A1 TN 2013000186A1 TN P2013000186 A TNP2013000186 A TN P2013000186A TN 2013000186 A TN2013000186 A TN 2013000186A TN 2013000186 A1 TN2013000186 A1 TN 2013000186A1
- Authority
- TN
- Tunisia
- Prior art keywords
- antibodies
- therapeutic
- compositions
- same
- relates
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
The present invention relates to anti - IL - 23pl9 binding compounds, in particular humanized anti - IL - 23pl9 antibodies and therapeutic and diagnostic methods and compositions for using the same.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2011/058869 WO2012061448A1 (en) | 2010-11-04 | 2011-11-02 | Anti-il-23 antibodies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TN2013000186A1 true TN2013000186A1 (en) | 2014-11-10 |
Family
ID=54360618
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNP2013000186A TN2013000186A1 (en) | 2011-11-02 | 2013-04-29 | Anti-il-23 antibodies |
Country Status (1)
| Country | Link |
|---|---|
| TN (1) | TN2013000186A1 (en) |
-
2013
- 2013-04-29 TN TNP2013000186A patent/TN2013000186A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12013500810B1 (en) | Anti-il-23 antibodies | |
| PH12014501108A1 (en) | Anti-il-36r antibodies | |
| PH12014502406A1 (en) | Anti-il-23p19 antibodies | |
| TN2012000462A1 (en) | Anti-cd40 antibodies | |
| SG184310A1 (en) | Antibodies that bind human cd27 and uses thereof | |
| MX2013009362A (en) | Antibody against the csf-1r. | |
| MX356337B (en) | Antibodies against human csf-1r and uses thereof. | |
| MX2020004503A (en) | Humanized or chimeric cd3 antibodies. | |
| TN2014000134A1 (en) | Therapeutic peptides | |
| MX2013007455A (en) | Anti-cd38 antibodies. | |
| MX2014002996A (en) | Bispecific anti-egfr/anti igf-1r antibodies. | |
| WO2012109238A3 (en) | Methods for increasing immune responses using agents that directly bind to and activate ire-1 | |
| MX2015004892A (en) | Methods and compositions relating to anti-il-21 receptor antibodies. | |
| AR123070A2 (en) | ANTI-IL-23 ANTIBODIES | |
| TN2013000186A1 (en) | Anti-il-23 antibodies | |
| TN2014000207A1 (en) | Anti il-36r antibodies | |
| TN2013000265A1 (en) | Anti-cd38 antibodies | |
| NZ626296A (en) | Compositions and methods for antibodies targeting factor p |